Lippoldt Darin bought NBIX

January 8, 2026 · Form 4 insider transaction

Lippoldt Darin bought 3,349 shares of Neurocrine Biosciences, Inc. at $35.99 per share, a transaction worth $120.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
3,349
Price
$35.99
Total value
$120.5K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after46,754
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR